BCL6 and neoplasm: Sample F16 could now be classified as “double-hit” (DH) for MYC and BCL2 rearrangements, sample F67 as a MYC and BCL6 DH tumor (with partners IGH and IGL), sample F194 as MYC and BCL2 and BCL6 triple hit (TH, although MYC and BCL6 fused together) and sample F209 as TH.